Citigroup’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-53,844
| Closed | -$517K | – | 5116 |
|
|
2024
Q4 | $517K | Buy |
53,844
+3,858
| +8% | +$37K | ﹤0.01% | 3000 |
|
|
2024
Q3 | $143K | Buy |
49,986
+34,604
| +225% | +$99K | ﹤0.01% | 3816 |
|
|
2024
Q2 | $44.9K | Buy |
15,382
+2,531
| +20% | +$7.39K | ﹤0.01% | 3918 |
|
|
2024
Q1 | $41K | Buy |
12,851
+3,023
| +31% | +$9.64K | ﹤0.01% | 3977 |
|
|
2023
Q4 | $33K | Buy |
9,828
+8,704
| +774% | +$29.2K | ﹤0.01% | 3986 |
|
|
2023
Q3 | $2.68K | Sell |
1,124
-20,586
| -95% | -$49K | ﹤0.01% | 4141 |
|
|
2023
Q2 | $38.2K | Sell |
21,710
-103,329
| -83% | -$182K | ﹤0.01% | 4097 |
|
|
2023
Q1 | $385K | Sell |
125,039
-38,636
| -24% | -$119K | ﹤0.01% | 2711 |
|
|
2022
Q4 | $867K | Buy |
163,675
+160,829
| +5,651% | +$852K | ﹤0.01% | 2136 |
|
|
2022
Q3 | $10K | Buy |
2,846
+1,444
| +103% | +$5.07K | ﹤0.01% | 4264 |
|
|
2022
Q2 | $4K | Sell |
1,402
-2,355
| -63% | -$6.72K | ﹤0.01% | 4948 |
|
|
2022
Q1 | $17K | Sell |
3,757
-5,303
| -59% | -$24K | ﹤0.01% | 4504 |
|
|
2021
Q4 | $62K | Buy |
9,060
+2,415
| +36% | +$16.5K | ﹤0.01% | 4200 |
|
|
2021
Q3 | $48K | Buy |
6,645
+708
| +12% | +$5.11K | ﹤0.01% | 4014 |
|
|
2021
Q2 | $59K | Buy |
5,937
+2,564
| +76% | +$25.5K | ﹤0.01% | 4074 |
|
|
2021
Q1 | $32K | Sell |
3,373
-1,032
| -23% | -$9.79K | ﹤0.01% | 4311 |
|
|
2020
Q4 | $48K | Buy |
4,405
+3,760
| +583% | +$41K | ﹤0.01% | 4125 |
|
|
2020
Q3 | $6K | Buy |
+645
| New | +$6K | ﹤0.01% | 4596 |
|